Search results
Jun 25, 2021 · Timothy Rittman is a senior clinical research associate at the University of Cambridge where he studies rare types of dementia, combining neuroimaging, cognitive assessments and neuropathology to understand how these diseases affect the whole brain.
View Dr Timothy Rittman’s profile on LinkedIn, a professional community of 1 billion members. Senior Clinical Research Associate at University of Cambridge · I lead a research group studying rare...
- 500+
- Peterhouse
- Royal College of Physicians
Dr Timothy Rittman is pleased to consider applications from prospective PhD students. Interests. My interests are to understand neurodegenerative tauopathies at the systems level, and to translate artificial intelligence algorithms into clinical practice for memory clinics. Collaborators. Associated News Items. Key Publications. Publications.
Dr Timothy Rittman. I am a Clinical Lecturer with both a clinical and research interest in the atypical parkinsonian disorders of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Multivariable logistic regression was utilized to examine the independent effect of intoxication on a patient’s likelihood of undergoing an urgent procedure, as well as the timing of the procedure. Results: Of the 33,646 patients with an isolated severe TBI, 11,313 (33.6%) were intoxicated.
Nov 20, 2009 · Background: 12-month results from TOPS showed an advantage for the high dose (800mg/day, HD-IM) arm for: (1) time to achievement of major molecular response (MMR); MMR rates at 3 and 6 months (mos); and (2) complete cytogenetic response (CCyR) at 6 mos (Guilhot et al. [TOPS] ASH 2008).
People also ask
Who is Dr. Tillman?
Who is Timothy Tillman?
Who is Timothy Rittman?
Andrew Blitzer, MD, DDS. Professor Emeritus of Otolaryngology-Head and Neck Surgery. Columbia University College of Physicians and Surgeons. Adjunct Professor of Neurology. Icahn School of Medicine at Mt. Sinai. Director. New York Center for Voice and Swallowing Disorders. Co-Founder and Director of Research. ADN International.
